The invention relates to novel 3-aryl-substituted imidazo[1,2-a]pyridines, to a method for producing same, to the use thereof individually or in combinations for the treatment and/or prophylaxis of diseases, and to the use thereof for producing medication for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular diseases.